FATE peer analysis

Fate Therapeutics (FATE) against its competitors: price, today's move, 1-year return and market value side by side.

FATE and its peers

CompanyPriceToday1-year returnMarket cap
ABOS Acumen Pharmaceuticals$0.18-9.11%-88.66%$12.71M
ALEC Alector$2.331.52%91.39%$347.63M
CRBP Corbus$2.09-14.17%-82.32%$43.07M
INO Inovio Pharmaceuticals$1.847.60%3.37%$127.13M
MOLN Molecular Partners$2.67-6.82%–$102.16M
NKTX Nkarta$1.152.68%-35.75%$82.37M
PEPG PepGen$3.79-3.56%-31.46%$262.50M
PRLD Prelude Therapeutics Incorporated$3.22-1.08%92.81%$257.83M
VOR Vor Biopharma$19.203.67%145.52%$1.18B
FATE Fate Therapeutics$0.96-5.06%-8.68%$116.57M